138 related articles for article (PubMed ID: 33533894)
1. Variations in Persistent Use of Low-Value Breast Cancer Surgery.
Wang T; Bredbeck BC; Sinco B; Shubeck S; Baskin AS; Skolarus T; Dossett LA
JAMA Surg; 2021 Apr; 156(4):353-362. PubMed ID: 33533894
[TBL] [Abstract][Full Text] [Related]
2. Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review.
Wang T; Baskin AS; Dossett LA
JAMA Surg; 2020 Aug; 155(8):759-770. PubMed ID: 32492121
[TBL] [Abstract][Full Text] [Related]
3. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
5. Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management.
Morrow M; Abrahamse P; Hofer TP; Ward KC; Hamilton AS; Kurian AW; Katz SJ; Jagsi R
JAMA Oncol; 2017 Oct; 3(10):1352-1357. PubMed ID: 28586788
[TBL] [Abstract][Full Text] [Related]
6. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Br J Surg; 2021 Sep; 108(9):1105-1111. PubMed ID: 34010418
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Oncologists' Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor-Positive Breast Cancer.
Minami CA; Bryan AF; Freedman RA; Revette AC; Schonberg MA; King TA; Mittendorf EA
JAMA Netw Open; 2022 Aug; 5(8):e2228524. PubMed ID: 36001314
[TBL] [Abstract][Full Text] [Related]
8. Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes.
Prathibha S; White M; Kolbow M; Hui JYC; Brauer D; Ankeny J; Jensen EH; LaRocca CJ; Marmor S; Tuttle TM
Breast Cancer Res Treat; 2024 May; 205(1):127-133. PubMed ID: 38281296
[TBL] [Abstract][Full Text] [Related]
9. Identification of Populations at Risk for "Choosing Un-Wisely": A SEER Population-Based Study.
Hong MJ; Lum SS; Ji L; Namm JP; Solomon NL; Garberoglio C; Vora H
Am Surg; 2023 Oct; 89(10):4135-4141. PubMed ID: 37259527
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
Hennigs A; Riedel F; Feißt M; Köpke M; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Heil J
Ann Surg Oncol; 2019 Aug; 26(8):2435-2443. PubMed ID: 31049766
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in low-value surgical care and time to surgery in high-volume hospitals.
Jackson DK; Li Y; Eskander MF; Tsung A; Oppong BA; Bhattacharyya O; Paskett ED; Obeng-Gyasi S
J Surg Oncol; 2021 Feb; 123(2):676-686. PubMed ID: 33616989
[TBL] [Abstract][Full Text] [Related]
12. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.
Hoskin TL; Hieken TJ; Degnim AC; Jakub JW; Jacobson SR; Boughey JC
Surgery; 2016 Apr; 159(4):1199-209. PubMed ID: 26704783
[TBL] [Abstract][Full Text] [Related]
13. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
[TBL] [Abstract][Full Text] [Related]
14. Institutional variation in surgical care for early-stage breast cancer at community hospitals.
Dodgion CM; Lipsitz SR; Decker MR; Hu YY; Quamme SRP; Karcz A; D'Avolio L; Greenberg CC
J Surg Res; 2017 May; 211():196-205. PubMed ID: 28501117
[TBL] [Abstract][Full Text] [Related]
15. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.
Yen TW; Laud PW; Sparapani RA; Nattinger AB
JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337
[TBL] [Abstract][Full Text] [Related]
16. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010.
Wilke LG; Czechura T; Wang C; Lapin B; Liederbach E; Winchester DP; Yao K
JAMA Surg; 2014 Dec; 149(12):1296-305. PubMed ID: 25390819
[TBL] [Abstract][Full Text] [Related]
17. National practice patterns of sentinel lymph node dissection for breast carcinoma.
Lucci A; Kelemen PR; Miller C; Chardkoff L; Wilson L
J Am Coll Surg; 2001 Apr; 192(4):453-8. PubMed ID: 11294401
[TBL] [Abstract][Full Text] [Related]
18. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO
Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048
[TBL] [Abstract][Full Text] [Related]
19. Barriers and Facilitators to De-Implementation of the Choosing Wisely
Smith ME; Vitous CA; Hughes TM; Shubeck SP; Jagsi R; Dossett LA
Ann Surg Oncol; 2020 Aug; 27(8):2653-2663. PubMed ID: 32124126
[TBL] [Abstract][Full Text] [Related]
20. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
